⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8767986 | 0.88 | — | — | |
| SCHEMBL719520 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL16341718 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL16341166 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL1311257 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL9323936 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL715302 | 0.85 | ALDH1A1 (0.72) | — | |
| SCHEMBL719096 | 0.82 | ALDH1A1 (0.67) | — | |
| SCHEMBL25275677 | 0.78 | ALDH1A1 (0.56) | — | |
| SCHEMBL9322072 | 0.78 | ALDH1A1 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021026179-A1 | AGONISTS OF ROR GAMMAt | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-02-11 | — | — | WO | disclosed |
| US-20110112193-A1 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | BIOLIPOX AB (SE) | 2011-05-12 | — | — | US | disclosed |
| EP-2294050-A2 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | Biolipox AB (SE) | 2011-03-16 | — | — | EP | disclosed |
| WO-2009138758-A2 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | BIOLIPOX AB (SE) | 2009-11-19 | — | — | WO | disclosed |
| EP-1037969-A4 | FIBRINOGEN-CONVERTING ENZYME HYBRIDS | BRISTOL MYERS SQUIBB CO (US) | 2003-05-21 | — | — | EP | disclosed |
| EP-1037969-A1 | FIBRINOGEN-CONVERTING ENZYME HYBRIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999029838-A1 | FIBRINOGEN-CONVERTING ENZYME HYBRIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-06-17 | — | — | WO | disclosed |